Sunday - May 17, 2026
LBS alumnus Will West leads $220m funding round for cancer treatment trials
May 17, 2026
LONDON, England, May 17 -- London Business School posted the following news:

* * *

LBS alumnus Will West leads $220m funding round for cancer treatment trials

*

London Business School alumnus Will West (MBA 2001), CEO and founder of CellCentric, has announced a $220m oversubscribed Series D financing to advance pivotal trials of the company's multiple myeloma treatment, inobrodib.

CellCentric, the Cambridge-based biotechnolog . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products